Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Editorial on “Developing Benchmarks in the Diagnosis and Treatment of Pulmonary Arterial Hypertension in a Tertiary, Academic Medical Center”
Frantz, Robert P. , Frantz, Robert P

Pulmonary Circulation | April 16, 2025 | Volume: 15 | Issue: 2 | Pages: No page available

10.1002/pul2.70081 | PMID 40241914 Get It

Approaches to reduce succinate accumulation by restoration of succinate dehydrogenase activity in cultured adrenal cells
Khazal, Fatimah Al, Rahimi, Leili , Feng, Fan , Becker, Nicole A. , Maher, L. James , Al Khazal, Fatimah, Folmes, Clifford D, III, Louis James Maher , Feng, Fan, Folmes, Clifford D.L. , Favier, Judith

Journal of Cell Science | April 16, 2025 | Volume: 138 | Issue: 9 | Pages: No page available

10.1242/jcs.263925 | PMID 40235395 Get It

ABSTRACT The rare human neuroendocrine tumors pheochromocytoma and paraganglioma (PPGL) can result from loss of mitochondrial succinate dehydrogenase. The resulting succinate accumulation is tumorigenic in certain neuroendocrine cells. Here, we explore two theoretical approaches to mitigate tumorigenic succinate accumulation in a cell culture model of PPGL. We first study a gene replacement strategy using transposition technology, and conclude that many of the changes in mitochondrial morphology, oxidative cell metabolism and succinate accumulation can be reversed by this process. We then investigate whether riboflavin supplementation has the potential to rescue succinate dehydrogenase activity in the intact SDHA catalytic subunit to suppress succinate accumulation even in the absence of SDHB. We show that this latter strategy is not successful.
Cost‐Effectiveness of Ferritin Screening Thresholds for Iron Deficiency in Reproductive‐Age Women
Sra, Manraj, Glaeser‐Khan, Samira , Moshashaian‐Asl, Ranya, Cuker, Adam , Goshua, George , Goshua, George , Wang, Daniel , Sra, Manraj, Wang, Daniel Y. , Ito, Satoko

American Journal of Hematology | April 16, 2025 | Volume: 100 | Issue: 7 | Pages: 1132-1140

10.1002/ajh.27686 | PMID 40235279 Get It

ABSTRACT Iron deficiency (ID) is a top five leading cause of disability‐adjusted life‐years in women of reproductive age around the world. Despite its enormous health burden, no screening guidelines exist for the detection and treatment of ID in women of reproductive age. We sought to determine the cost‐effectiveness of screening versus no screening for ID in women of reproductive age in the United States. A lifetime simulation of women of reproductive age was conducted using a Markov cohort model under three strategies: (1) no screening, (2) screening at a ferritin threshold of 15 μg/L, and (3) screening at a ferritin threshold of 25 μg/L, from the US health system perspective, and at a willingness‐to‐pay threshold of $100 000/quality‐adjusted life year (QALY). Epidemiologically informed ID prevalence estimates sourced from the National Health and Nutrition Examination Survey were employed for model parameterization. The primary outcome was the incremental cost‐effectiveness ratio (ICER, in $/QALY). Base‐case results for the three strategies accrued $209 700, $210 200, and $210 200 discounted lifetime costs and 23.6, 24.0, and 24.4 discounted lifetime QALYs, respectively. Screening at a ferritin threshold of 25 μg/L was the cost‐effective intervention with an ICER of $680/QALY (95% credible interval $350–$750/QALY). In dual base‐case analyses examining intravenous rather than oral iron repletion for treatment, screening at a ferritin threshold of 25 μg/L remained the cost‐effective intervention with an ICER of $2300/QALY (95% CI $1800–$3800/QALY). In probabilistic sensitivity analyses, screening at a ferritin threshold of 25 μg/L was the cost‐effective intervention in 100% of 10 000 second order Monte Carlo iterations.
Electrochemical Catheter Hub Operated by a Wearable Micropotentiostat Prevents Acinetobacter baumannii Infection In Vitro
Al‐Qurahi, Majid , Kim, Won‐Jun , Bozyel, Ibrahim , Patel, Robin , Beyenal, Haluk , Fleming, Derek , Kim, Won-Jun , Bozyel, Ibrahim , Patel, Robin , Beyenal, H , Fleming, Derek

Biotechnology and Bioengineering | April 16, 2025 | Volume: 122 | Issue: 7 | Pages: 1828-1839

10.1002/bit.28990 | PMID 40235195 Get It

ABSTRACTIntraluminal infection of central venous catheters, used for long‐term treatment, can result in central line‐associated bloodstream infection (CLABSI). These infections can be challenging to prevent and treat due to formation of biofilms within catheter lumens, which shield bacteria from the human immune response and conventional antimicrobial therapies. Preventing bacterial colonization of catheter hubs is a strategy to prevent CLABSI. To address this, we developed a nonantibiotic, animal‐ready electrochemical catheter hub (e‐catheter hub), operated by a wearable, battery‐powered micropotentiostat (MP), that internally generates tunable hypochlorous acid (HOCl) for preventing intraluminal infection. The design evaluated three different electrode materials—titanium, platinum, and gold—for HOCl generation and biocidal activity, using working and counter electrodes of the same materials and a silver/silver chloride‐plated wire as a quasi‐reference electrode. e‐catheter hubs operated by MPs at 1.5 VAg/AgCl for 3 h generated HOCl, reducing Acinetobacter baumannii ATCC‐17978 below the detection limit (average reduction of 4.40 ± 0.05 log10 CFU/mL). The efficacy of e‐catheter hubs operated by MPs in generating HOCl and achieving biocidal activity is comparable to that of a commercial potentiostat. This study represents the first step in developing a localized, nonantibiotic strategy to mitigate CLABSI risk.
Hospitalization and Mortality Among Mexican Adults With Arthritis: Findings From the Mexican Health and Aging Study
Rizzo, Alan Villarreal , Camarillo, Joe D, Khalife, Wissam, Peek, M. Kristen, Villarreal Rizzo, Alan F , Camarillo, Joe, Downer, Brian G.

Journal of Aging and Health | April 16, 2025 | Volume: 38 | Issue: 5-6 | Pages: 285-291

10.1177/08982643251335529 | PMID 40235176 Get It

Objectives Few studies have investigated health outcomes associated with arthritis in low-middle-income countries. Our objective was to examine the association between arthritis and all-cause hospitalization and mortality among middle-aged and older adults in Mexico. Methods Our sample included 12,106 participants aged >50 years from the 2012, 2015, and 2018 waves of the Mexican Health and Aging Study. Logistic regression was used for the associations between arthritis and hospitalization. Kaplan–Meier and Cox proportional hazard models were used for the association between arthritis and mortality. Results Arthritis was associated with higher odds of hospitalization (OR = 1.23; 95% CI = 1.09–1.38), but not mortality. Arthritis with physical limitations had the highest odds of hospitalization (OR = 1.48; 95% CI = 1.27–1.73). Arthritis with joint pain (OR = 1.24; 95% CI = 1.10–1.41) and medication use (OR = 1.28; 95% CI = 1.11–1.48) had higher odds of hospitalization. Conclusion Among middle-aged and older adults in Mexico, arthritis was associated with a high risk of hospitalization.
The CentiMarker project: Standardizing quantitative Alzheimer's disease fluid biomarkers for biologic interpretation
Wang, Guoqiao , Li, Yan, Xiong, Chengjie , Cao, Yuchen , Blennow, Kaj, Dage, Jeffrey L. , Jack, Clifford R. , Shaw, Leslie M. , Initiative, the Alzheimer's Disease Neuroimaging, Bateman, Randall J., Wang, Guoqiao , Jack, Clifford R , Dage, Jeffrey L , Li, Yan , Xiong, Chengjie , Cao, Yuchen, Schindler, Suzanne E. , McDade, Eric , Blennow, Kaj , Hansson, Oskar , Teunissen, Charlotte E. , Zetterberg, Henrik , Ibanez, Laura , Timsina, Jigyasha , Cruchaga, Carlos , Initiative, the Alzheimer's Disease Neuroimaging, Bateman, Randall J.

Alzheimer's & Dementia | April 16, 2025 | Volume: 21 | Issue: 4 | Pages: No page available

10.1002/alz.14587 | PMID 40235082 Get It

Abstract INTRODUCTION Biomarkers play a crucial role in understanding Alzheimer's disease (AD) pathogenesis and treatment effects. However, comparing biomarker measures without standardization and appreciating their magnitude relative to the disease can be challenging. METHODS To address this issue, we propose the CentiMarker approach, similar to Centiloid, which provides a standardized scale between normal (0) and nearly maximum abnormal AD (100) ranges. We applied this scale to cerebrospinal fluid (CSF) biomarkers in dominantly inherited AD and sporadic AD cohorts. RESULTS CentiMarkers facilitated the interpretation of disease abnormality, demonstrating comparable changes and distributions of AD biomarkers across disease stages. CentiMarkers make the treatment effect more comparable than their original scales across various biomarkers. DISCUSSION The versatility of CentiMarkers makes it a valuable tool for standardized biomarker comparison in AD research, enabling informed cross‐study comparisons and contributing to accelerated therapeutic development. Adoption of the CentiMarker scale could enhance biomarker reporting and advance our understanding of AD. Highlights Comparing fluid biomarkers without appreciating their magnitude relative to the disease can be challenging. We propose a CentiMarker metric to standardize biomarker measures from normal (0) and nearly maximum abnormal AD (100) ranges. CentiMarkers make the treatment effect more comparable across various biomarkers than when using the original scales.
Pulmonary Toxicities in Pediatric Patients Treated With Total Body Irradiation Using the Lateral Opposed Fields Technique
Boyce, N, Harmsen, William S. , Boyce, Sharon, Dahl, Robert A. , Laack, Nadia N. , Boyce, Natalie, Ahmed, Safia, Dahl, Robert, Laack, Nadia N Issa , Ahmed, Safia K. , Boyce, Sharon

Pediatric Blood & Cancer | April 15, 2025 | Volume: 72 | Issue: 7 | Pages: No page available

10.1002/pbc.31713 | PMID 40235028 Get It

ABSTRACT Purpose Pulmonary toxicity (PT) remains a concern following total body irradiation (TBI). This study describes the incidence and factors associated with PT in a cohort of patients homogeneously treated with the lateral opposed fields technique. Methods Medical records of 61 patients ≤21 years of age treated with TBI as a component of stem cell transplantation from 1993–2017 were retrospectively reviewed. The incidences of PT, graft‐versus‐host disease (GVHD), and other toxicities were recorded for each patient. PT was subdivided into its etiologies, and symptomatic PT was established by clinical diagnosis. The association of PT with other variables was examined using chi‐square tests, and overall survival (OS) was estimated using Kaplan–Meier. Results Three‐year OS was 65% (54%–79%). Median TBI dose rate was 7.7 cGy/min (4.0–10 cGy/min). PT occurred in 20 patients (33%). A higher rate of PT was observed in patients with GVHD (65% vs. 35%, p ≤ 0.01). TBI dose rate (</≥ 7.7 cGy/min) was not associated with the risk of PT; however, on continuous analysis, a higher dose rate increased the risk of PT (HR = 1.9, p = 0.04). PT (HR = 3.4, p = 0.01), noninfectious PT (HR = 5.0, p ≤ 0.01), and pneumonitis (HR = 4.3, p = 0.01) were associated with inferior OS. Conclusions This cohort of patients treated with a low dose rate, bilateral technique, and total dose of 1000–1320 cGy experienced an acceptable incidence of PT, comparable to other published studies. Because PT correlated with reduced survival, current practice should seek to address factors associated with PT by aiming to prevent GVHD and by choosing low dose rates, such as in the range of 4.0–10 cGy/min.
Anatomical Considerations for Endovascular Penile Interventions
Naidu, Sailendra , Patel, Indravadan , Alzubaidi, Sadeer , Wallace, Alex, Crawford, Daniel , Punjani, Nahid

Seminars in Interventional Radiology | April 15, 2025 | Volume: 42 | Issue: 02 | Pages: 229-233

10.1055/s-0045-1804491 | PMID 40376213 Get It

AbstractDue to multiple medical advances over the past several years, angiographic investigation into arterial insufficiency as the cause of erectile dysfunction has decreased. Due to this, there is a general lack of familiarity with penile angiography technique and arterial anatomy, among current practicing interventional radiologists. Some potential indications for penile angiography include evaluation of penile trauma, high-flow priapism, further diagnostic evaluation of an abnormal penile Doppler ultrasound, or in the evaluation or treatment of erectile dysfunction with endovascular or surgical treatments. These indications, although relatively rare, still require practicing IRs to be familiar with angiographic anatomy of the penis. This article will briefly review angiographic technique in penile angiography with an emphasis on arterial anatomy.
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for stage III melanoma: outcomes and the impact of the microbiome from the NeoACTIVATE trial
Block, Matthew S. , Nelson, Garth D. , Chen, Jun , Johnson, Stephen , Yang, Lu , Flotte, Thomas J. , Grewal, Eric P. , McWilliams, Robert R. , Kottschade, Lisa A. , Domingo‐Musibay, Evidio , Montane, Heather N. , Hui, Jane Yuet Ching , Erskine, Courtney L. , Zahrieh, David , Flotte, Thomas James , Markovic, Svetomir , Dimou, Anastasios , Montane, Heather N , Piltin, Mara , Price, Daniel L , Khariwala, Samir S , Hui, Jane Yuet Ching , Erskine, Courtney L , Strand, Carrie A , Zahrieh, David , Dong, Haidong , Hieken, Tina J , McWilliams, Robert R , Chen, Jun , Grewal, Eric P , Johnson, Stephen , Markovic, Svetomir N. , Dimou, Anastasios , Piltin, Mara A. , Price, Daniel L. , Strand, Carrie , Dong, Haidong , Hieken, Tina J.

Journal for ImmunoTherapy of Cancer | April 15, 2025 | Volume: 13 | Issue: 4 | Pages: e011706

10.1136/jitc-2025-011706 | PMID 40234093 Get It

Background Neoadjuvant treatment has become standard for patients with high-risk operable stage III melanoma, but the optimal regimen is unknown. Targeted therapy approaches yield high pathological response rates, while immunotherapy regimens show favorable recurrence-free survival (RFS). NeoACTIVATE was designed to address whether a neoadjuvant combination of both targeted therapy and immunotherapy might leverage the benefits of each. Methods We tested neoadjuvant treatment with 12 weeks of vemurafenib, cobimetinib, and atezolizumab for patients with BRAF-mutated (BRAFm) melanoma (cohort A) and cobimetinib and atezolizumab for patients with BRAF-wild-type (BRAFwt) melanoma (cohort B), regimens which we have shown generate a substantial major pathological response. After therapeutic lymph node dissection, patients received 24 weeks of adjuvant atezolizumab. Here, we report survival outcomes and their association with biomarkers assayed among the gut microbiome and peripheral blood immune subsets. Results With 49 months median follow-up, the median RFS was not reached for cohort A and was 40.8 months for cohort B. At 24 months after operation, 2 of 14 cohort A patients and 4 of 13 cohort B patients had experienced distant relapse. Key findings from correlative analyses included diversity, taxonomic and functional metagenomic gut microbiome signals associated with distant metastasis-free survival at 2 years. Notably, we observed a strong correlation between low microbial arginine biosynthesis (required for T-cell activation and effector function) and early distant recurrence (p=0.0005), which correlated with taxonomic differential abundance findings. Peripheral blood immune monitoring revealed increased double-positive (CD4+CD8+) T cells in patients with early recurrence. Conclusions Neoadjuvant treatment with cobimetinib and atezolizumab±vemurafenib was associated with a low rate of distant metastasis in patients with high-risk stage III melanoma. Freedom from early distant metastasis was highly associated with taxonomic differences in gut microbiome structure and with functional pathway alterations known to modulate T cell immunity. Identification of predictive biomarkers will permit optimization of neoadjuvant therapy regimens for individual patients. Trial registration number NCT03554083.
Mini-invasive Anterior Petrosal Intertentorial Approach for Trigeminal Neuralgia: Rationale and Limits of the Technique
Giammattei, Lorenzo , Peters, David R. , Mellal, Amine , Starnoni, Daniele, Daniel, Roy Thomas , Peters, D , Squair, Jordan W. , Fava, Arianna , Aureli, Viviana , Pistocchi, Silvia

Journal of Neurological Surgery Part B: Skull Base | April 15, 2025 | Volume: 87 | Issue: 02 | Pages: 144-150

10.1055/a-2587-6267 | PMID 41808976 Get It

Abstract The retrosigmoid approach (RSA) is considered the standard surgical choice to address a neurovascular conflict involving the trigeminal nerve. The subtemporal transtentorial approach (STA) represents the main alternative. We describe here the mini-invasive anterior petrosal intertentorial approach with a view to reduce complications associated with the standard STA. Mini-invasive anterior petrosal intertentorial approach (M-APIA) was described for a case of refractory trigeminal neuralgia. This approach includes a very limited amount of drilling of the petrous ridge to expose the posterior fossa dura and the superior petrosal sinus to facilitate the subsequent tentorial peeling. Tentorial peeling enables to develop an intertentorial plane between the temporal tentorial leaf (TTL) and the posterior fossa tentorial leaf (PFTL). A linear incision over the posterior fossa dura and the PFTL offers a wide exposure of the neurovascular conflict. M-APIA enables to expose the root entry zone (REZ) of the trigeminal nerve without exposing the temporal lobe or the cerebellum. M-APIA can be considered as a safe alternative to the RSA or STA for trigeminal microvascular decompression (MVD), especially for select cases. Additional studies are needed for a better understanding of its advantages and disadvantages.